Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Cellular and Molecular Medicine|August 30, 2018
Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonistChengying Xie, Huajun Zhao, Xubin Bao, et al.
Bioscience Reports|April 10, 2020
Early differential diagnosis model for acute radiation pneumonitis based on multiple parametersZhiwu Wang, Qiong Wu, Liang Dong, et al.
The Clinical Respiratory Journal|May 9, 2024
Abnormal methylation mediated upregulation of LINC00857 boosts malignant progression of lung adenocarcinoma by modulating the miR-486-5p/NEK2 axisHaoyu Fu, Mingming Zhang, Xiaohui Liu, et al.
Journal of Fungi (Basel, Switzerland)|April 26, 2024
Five New Species of the Genus <i>Hymenogaster</i> (Hymenogastraceae, Agaricales) from Northern ChinaTing Li, Ning Mao, Haoyu Fu, et al.
ACS Applied Materials & Interfaces|July 12, 2016
Impacts of Surface Energy on Lithium Ion Intercalation Properties of V2O5Wenda Ma, Changkun Zhang, Chaofeng Liu, et al.
Journal of Agricultural and Food Chemistry|June 2, 2026
From Rational Design to Bioactivity Enhancement: Novel Benzofuranone Insecticide Discovery Assisted by a Calix[4]arene-Based Supramolecular StrategyRenxuan Zou, Jinyang Zhou, Ziyan Yang, et al.
ACS Applied Materials & Interfaces|March 1, 2017
Continuous Size Tuning of Monodispersed ZnO Nanoparticles and Its Size Effect on the Performance of Perovskite Solar CellsRong Zhang, Chengbin Fei, Bo Li, et al.
American Journal of Cancer Research|February 13, 2023
Combined inhibition of PARP and ATR synergistically potentiates the antitumor activity of HER2-targeting antibody-drug conjugate in HER2-positive cancersYongpeng Li, Lin Li, Haoyu Fu, et al.
International Journal of Oncology|October 17, 2025
Therapeutic potentials of plant‑based antioxidants on colorectal cancer: Challenges and perspectives (Review)Daan Fu, Haoyu Fu, Yafeng Wang, et al.
Thoracic Cancer|March 3, 2021
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cellsMi Zhang, Haitian Quan, Li Fu, et al.
Pageof 5